KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
123 hedge funds and large institutions have $253M invested in Keryx Biopharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 42 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
123
Holding in Top 10
–
Calls
$1.1M
Puts
$1.46M
Top Buyers
| 1 | +$3.47M | |
| 2 | +$1.99M | |
| 3 | +$1.95M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.1M |
| 5 |
Citigroup
New York
|
+$729K |
Top Sellers
| 1 | -$2.86M | |
| 2 | -$2.54M | |
| 3 | -$965K | |
| 4 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
-$747K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$573K |